
N-(4-Hydroxyphenyl)retinamide
CAS :
Ref. IN-DA003QL2
1g
539,00€
1mg
49,00€
10mg
52,00€
25mg
75,00€
50mg
108,00€
100mg
157,00€
250mg
238,00€

- Vitamins
- Antitumoral
- APIs for research and impurities
- Apoptosis
- Cancer Research
- Biochemicals and Reagents
- Cellular and Molecular Biology
- Nutrition Research
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)
Informations sur le produit
Nom:N-(4-Hydroxyphenyl)retinamide
Synonymes :
- 13-cis-Isomer Fenretinide
- 4 Hydroxyphenylretinamide
- 4-Hydroxyphenylretinamide
- Fenretinide
- Fenretinide, 13 cis Isomer
- Fenretinide, 13-cis-Isomer
- Fenretinimide
- N-(4-Hydroxyphenyl)-trans-Retinamide
- 4-hydroxyphenylretinamide
- 4-Hydroxyphenyl retinamide
- Retinoic acid p-hydroxyanilide
- all-trans-4'-Hydroxyretinanilide
- Fenretinida
- Fenretinidum
- 4-hydroxy(phenyl)retinamide
- N-(4-Hydroxyphenyl)all-Trans Retinamide
- Fenretinidum [Latin]
- Fenretinida [Spanish]
- Retinoic acid p-hydroxyphenylamide
- Retinamide, N-(4-hydroxyphenyl)-
- 4-(hydroxyphenyl)retinamide
- 15-[(4-hydroxyphenyl)amino]retinal
- N-(4-Hydroxyphenyl)-all-trans Retinamide
- (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide
- Fenretinimide
- (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide
- (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide
- N-(4-Hydroxyphenyl)-trans-Retinamide
- p-Hydroxyphenylretinamide
- Retinamide,N-(4-hydroxyphenyl)-
- 15-(4-Hydroxyanilino)retinal #
- (2Z,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide
- 1-enyl)nona-2,4,6,8-tetraenamide
- all-trans-n-(4-hydroxyphenyl)retinamide
- dimethyl-9-(2,6,6-trimethylcyclohex-
- Retinoic acid p-hydroxyanilide, >=95%
- (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamide
- (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-
- (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide
- 2,6,8-Nonatetraenamide, N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl-, (all-E)-
- 3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide
- N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraeneamide
- N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide
- Methyl 4-fluorobenzoate
- 4 Hydroxyphenylretinamide
- 13-cis-Isomer Fenretinide
- Fenretinide, 13 cis Isomer
- Fenretinide, 13-cis-Isomer
- Fenretinide (intravenous, cancer), SciTech Development
- Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products
- Fenretinide (topical, actinic keratosis and cancer), SciTech Development
- Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles
- Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx
- Voir plus de synonymes
Marque:Indagoo
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Masse moléculaire :391.5457
Formule :C26H33NO2
Degré de pureté :98%
Couleur/Forme :Solid
InChI :InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+
Code InChI :AKJHMTWEGVYYSE-FXILSDISSA-N
Question d’ordre technique à propos de: N-(4-Hydroxyphenyl)retinamide
Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande
Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande. Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages.